Obamacare Will Affect Research

The Supreme Court's decision to uphold President Barack Obama's health care reform law contains key provisions that will impact US science funding in the years to come.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

US Supreme CourtWIKIMEDIA COMMONS, ©JAREK TUSZYNSKI

In an historic moment, the US Supreme Court voted 5-4 yesterday (June 28) to uphold President Barack Obama's health care reform law—colloquially known as the Affordable Care Act—by declaring the law's so-called "individual mandate," which levies a tax or fine if individual citizens fail to carry health insurance, constitutionally valid. Though it is the general public that will feel the main impact of the health care law, the legislation also includes key provisions, protected by today's ruling, that benefit biomedical research.

"With this ruling, what we have is the turning of a page and a new chapter," said Mary Wooley, CEO of science advocacy group Research!America. "It is time to be talking about research and innovation as a major driver in health care."

The key ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours